WEST PHARM.SVCS DL-25/ US9553061055 /
| 07.11.2024 07:57:06 | Diff. +0,1000 | Volumen | Geld08:25:31 | Brief08:25:31 | Marktkapitalisierung | Dividendenr. | KGV |
|---|---|---|---|---|---|---|---|
| 307,2000EUR | +0,03% | - Umsatz: - |
303,8000Geld Vol: 30 | 308,7000Brief Vol: 30 | 22,22 Mrd.EUR | - | - |
Aktiva
| 2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
2022 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sachanlagen | 822 | 839,3000 | 943,2000 | 1.057,5000 | 1.158,3000 | ||||||
| Immaterielle Vermögensgegenstände | 20,3000 | 29,8000 | 30,5000 | 23 | 18,4000 | ||||||
| Finanzanlagen | - | - | - | - | - | ||||||
| Anlagevermögen | 1.084,5000 | 1.282,7000 | 1.420,1000 | 1.571,8000 | 1.697,3000 | ||||||
| Vorräte | 214,5000 | 235,7000 | 321,3000 | 378,4000 | 414,8000 | ||||||
| Forderungen | 288,2000 | 319,3000 | 385,3000 | 489 | 507,4000 | ||||||
| Liquide Mitteln | 337,4000 | 439,1000 | 615,5000 | 762,6000 | 894,3000 | ||||||
| Umlaufvermögen | 894,4000 | 1.058,7000 | 1.373,7000 | 1.742 | 1.919,5000 | ||||||
| Aktiva, gesamt | 1.978,9000 | 2.341,4000 | 2.793,8000 | 3.313,8000 | 3.616,8000 | ||||||
Passiva
| 2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
2022 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Verbindlichkeiten aus Lieferungen und Leistungen | 130,4000 | 156,8000 | 213,1000 | 232,2000 | 215,4000 | ||||||
| Langfristige Schulden | 196 | 255 | 252,9000 | 208,8000 | 206,7000 | ||||||
| Verbindlichkeiten gegenüber Kreditinstituten | ,1000 | 2,3000 | - | - | - | ||||||
| Rückstellungen | 22,9000 | 21,9000 | - | - | - | ||||||
| Verbindlichkeiten | 582,6000 | 768,2000 | 939,3000 | 978,4000 | 931,9000 | ||||||
| Gezeichnetes Kapital | 18,8000 | 18,8000 | 18,8000 | 18,8000 | 18,8000 | ||||||
| Eigenkapital | 1.396,3000 | 1.573,2000 | 1.854,5000 | 2.335,4000 | 2.684,9000 | ||||||
| Minderheitenanteile | - | - | - | - | - | ||||||
| Passiva, gesamt | 1.978,9000 | 2.341,4000 | 2.793,8000 | 3.313,8000 | 3.616,8000 | ||||||
Gewinn- und Verlustrechnung
| 2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
2022 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 1.717,4000 | 1.839,9000 | 2.146,9000 | 2.831,6000 | 2.886,9000 | ||||||
| Abschreibungen (Gesamt) | - | - | - | - | - | ||||||
| Betriebsergebnis | 240,3000 | 296,6000 | 406,9000 | 752,3000 | 734 | ||||||
| Zinsergebnis | 8,4000 | 8,5000 | 8,2000 | 8,2000 | 7,9000 | ||||||
| Ergebnis vor Steuern | 240,7000 | 291,8000 | 401,3000 | 748,9000 | 679,9000 | ||||||
| Ertragsteuern | 41,4000 | 59 | 72,5000 | 107,2000 | 114,7000 | ||||||
| Gewinnanteil Minderheitsgesellschafter | - | - | - | - | - | ||||||
| Konzernjahresüberschuss | 206,9000 | 241,7000 | 346,2000 | 661,8000 | 585,9000 | ||||||
Pro Aktie
Cash Flow
| 2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
2022 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow aus laufender Geschäftstätigkeit | 288,6000 | 367,2000 | 472,5000 | 584 | 724 | ||||||
| Cash Flow aus Investitionstätigkeit | -100,8000 | -228 | -179,5000 | -253,1000 | -288,2000 | ||||||
| Cash Flow aus Finanzierungstätigkeit | -80,7000 | -36,8000 | -137,1000 | -168,1000 | -293,6000 | ||||||
| Veränderung der liquiden Mittel | 101,5000 | 101,7000 | 176,4000 | 147,1000 | 131,7000 | ||||||
| Anzahl der Mitarbeiter | 7.700 | 8.200 | - | - | - | ||||||
